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his study aimed to investigate the ability of Tualang honey (TH), a phytoestrogen, to reduce blood oxidative stress levels/activities
in postmenopausal women and compared the efects with the standard estrogen progestin therapy (EPT). A total of 78 healthy
postmenopausal women were randomly assigned to one of two groups; EPT group received Femoston conti 1/5 (1mg 17�-
estradiol and 5mg dydrogesterone), and TH group, received 20 g of TH supplement daily for 16 weeks. he reduced glutathione to
oxidized glutathione ratio (GSH :GSSG), plasma glutathione peroxidase (GPx), catalase (CAT), superoxide dismutase (SOD), and
4-hydroxynonenal (4-HNE) levels/activities were measured at pre- and postinterventions using commercially available kits. he
plasma GPx and CAT activities were notably increased, and plasma 4-HNE level was signiicantly decreased in postmenopausal
women who received EPT and TH supplementation. TH supplementation for 16 weeks was able to reduce blood oxidative stress
levels/activities of postmenopausal women comparable to those who received EPT. hus, TH has a potential to be used as
antioxidant therapy to combat oxidative stress-induced neurodegenerative diseases. his trial is registered with NCT01300676.
1. Introduction
Studies have shown that oxidative stress is increased in
postmenopausal women, and it was reversed by antioxidant
action of estrogen [1–3]. he antioxidant action of estrogens
in vivo is due not to their chemical phenolic structure but
rather to their interaction with estrogen receptors in cells
which eventually lead to the activation of mitogen activated
protein kinases (MAPK) and nuclear factor kappa B (NF�B)
[4, 5]. Despite the proven beneit of hormone replacement
therapy (HRT), beliefs about side efects and concerns about
safety hinder the acceptance of HRT among patients even in
recent researches [6]. Hence, there is a need to ind a com-
parable alternative treatment to alleviate postmenopausal
symptoms.
Honey contains various kinds of phytochemicals with
high phenolic and lavonoid content which contribute to
its high antioxidant activity [7, 8]. Flavonoids and other
polyphenols, common constituents of honey, have the poten-
tial to impound metal ions in complexes, preventing the
formation of free radicals [9]. Malaysian Tualang honey (TH)
is reported to have the highest antiradical activity compared
to Gelam honey, Indian forest honey, and Pineapple honey
[10] and a total of six phenolic acids and ive lavonoids [10–
12]. Recently, our research group has reported the beneicial
efects of estrogen progestin therapy (EPT) and TH on verbal
memory of postmenopausal women [13]. hese led us to
hypothesize that both EPT and TH improved verbal memory
of postmenopausal women by reducing blood oxidative stress
levels/activities. herefore, the aim of this study was to
compare the blood oxidative stress levels/activities of post-
menopausal women receiving EPT and TH supplementation.
2. Materials and Methods
2.1. Study Subjects. his study involved 78 postmenopausal
women aged between 45 and 60 years, recruited from the
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Family Medicine and the Obstetrics and Gynecology Clinic,
Hospital Universiti Sains Malaysia (USM). Participants were
excluded if they took any other herbal or hormone replace-
ment therapy 3 months prior to the study, smoked, had a his-
tory of drug or alcohol abuse, or had a history of seriousmed-
ical, surgical, mental, or gynecological diseases. Selected par-
ticipants underwent physical examinations including pelvic
ultrasonography to exclude any gynecological problems.
2.2. Study Procedure and Design. he study protocol was
approved by the Research and Ethics Committee of USM.
Participants were briefed on the nature of the study, and
informed consent was obtained at the initial visit. Ran-
domization was computer generated, and participants were
identiied by their hospital registration numbers and were
randomly assigned to one of two groups: TH and EPT groups.
he TH group received oral TH (AgroMas) at a daily dose of
20 g. he EPT group received oral Femoston 1/5 (1mg 17�
estradiol and 5mg dydrogesterone) daily. Participants took
the treatment for 16 weeks, and their health status, compli-
ance, and possible adverse efects were monitored every 8
weeks.
2.3. Determination of Blood Oxidative Stress Levels/Activities.
he blood GSH to GSSG ratio, plasma catalase (CAT), super-
oxide dismutase (SOD), and glutathione peroxidase (GPx)
were determined using a commercially available kit (Cal-
biochem, Darmstadt, Germany). Plasma 4-hydroxynonenal
(4-HNE) and total protein were determined using the OxiS-
elect HNE-His adduct Elisa kit (Cell Biolabs, Inc., San Diego,
USA) and Protein Assay kit (Bio-Rad, Hercules, CA, USA),
respectively. Procedures for the veriication of antioxidant
enzymes lipid oxidative damage and total protein were in
accordance with the manufacturer’s protocol.
2.4. Statistical Analysis. he results were analyzed using
PASW Statistics version 20 sotware. Values of outcome
data are expressed as mean and standard error of mean
(SEM). Demographic data were characterized using descrip-
tive statistics and group comparisons were conducted using
repeated measures ANOVA. he diferences in blood oxida-
tive stress values between pre- and postinterventions were
analyzed using paired �-test when within-group diference in
repeated measures ANOVA was signiicant. � < 0.05 was
considered statistically signiicant.
3. Results
A total of 78 postmenopausal women successfully completed
this study and the participants’ characteristics are summa-
rized in Table 1. here was no signiicant diference in the
mean age of participant, mean age of menarche, mean age
of menopause, and duration of menopause between EPT and
TH groups. EPT was used as active comparator since it is
the standard-of-care therapy. In the present study, there were
no group diferences in the preintervention values of blood
oxidative markers. hese data relect that the baseline values
Table 1: Characteristics of the participants.
Characteristics
Group
TH EPT
Age (years) 55.44 (0.52) 55.31 (0.49)
Menarche age (years) 13.28 (0.25) 13.87 (0.27)
Menopausal age (years) 50.08 (0.46) 49.21 (0.79)
Duration of menopause (years) 5.33 (0.53) 6.28 (0.73)
Values are expressed as mean (SEM). TH: Tualang honey; EPT: estrogen
progestin therapy. Statistical comparisons were made between groups using
independent �-test. a� < 0.05 was considered statistically signiicant.
were similar in both groups at the start of the study and were
used as control values.
he level/activity of oxidative stress markers between the
two groups was analyzed using repeated measures ANOVA.
here were signiicant diferences between the two groups in
mean CAT activity (�1,76 = 36.73 and � ≤ 0.001), GPx activ-
ity (�1,76 = 10.309 and � = 0.02), and 4-HNE level (�1,76 =
7.587 and � = 0.007). However, there were no signiicant
diferences between the two groups in mean SOD activity
(�1,76 = 1.045 and � = 0.310) and GSH/GSSG ratio (�1,76 =
0.062 and � = 0.804). he diferences in mean CAT activity,
GPx activity, and 4-HNE level between pre- and postin-
terventions were further analyzed using paired �-test. Dif-
ferences in the levels/activities of oxidative stress marker
between pre- and postinterventions were summarized in
Table 2.
4. Discussion
here was a signiicant increase in CAT activity ater 16 weeks
of EPT, and these results were in contrast with previous stud-
ies conducted on postmenopausal women. Previous studies
reported that CAT activity displayed minute diferences
between treated and nontreated postmenopausal women [14]
and between premenopausal and postmenopausal women
[15].he discrepancy could be due to diferent age groups and
duration of HRT used in the studies.
he increased CAT activity in TH group could be
explained by its antioxidant contents such as glucose oxi-
dase, diastase, invertase, catalase, and peroxidase and other
bioactive constituents [16]. Our indingwas also supported by
previous animal studies that showed restoration ofCATactiv-
ity in the erythrocytes of young and middle-aged rats [17],
pancreas of diabetic rats [18], and liver of male BALB/c mice
administered trichlorfon [19] following honey supplementa-
tion.
GPx activity was found to be signiicantly increased ater
16 weeks of EPT and was consistent with previous studies
[1, 20]. here was a signiicant increase in GPx activity ater
3 and 6 months of Premarin and Provera therapy in post-
menopausal women [1]. In addition, the erythrocytes GPx
were positively correlated with serum estrogen levels in both
premenopausal women and HRT-treated postmenopausal
women [20]. Estrogen has been suggested to exert its antiox-
idant efects via the modulation of intracellular GPx activity
[20].
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Table 2: Blood oxidative stress level/activity of the participants at pre- and postinterventions.
Markers
TH (� = 39) EPT (� = 39)
Pre Post Pre Post
Blood GSH :GSSG ratio 25.2 (7.6) 39.7 (11.5) 32.7 (8.0) 22.4 (6.9)
Plasma SOD (U/mL) 0.068 (0.005) 0.060 (0.005) 0.068 (0.006) 0.069 (0.005)
Plasma CAT (nmol/min/mL) 4.1 (0.5) 5.6 (0.5)a 4.1 (0.4) 6.4 (0.5)a
Plasma GPx (nmol/min/mL) 75.3 (5.5) 90.1 (6.5)a 83.5 (5.7) 105.8 (8.3)a
Plasma 4-HNE (�g/mL) 3.6 (0.23) 3.1 (0.23)a 3.4 (0.28) 2.6 (0.24)a
Values are expressed as mean (SEM). TH: Tualang honey; EPT: estrogen progestin therapy; GSH :GSSG: ratio of reduced to oxidized glutathione; GPx:
glutathione peroxidase; 4-HNE: 4-hydroxynonenal; CAT: catalase; SOD: superoxide dismutase. Statistical comparisons were made between pre- and
postinterventions using paired t-test, and a� < 0.05 was considered statistically signiicant.
he increase in GPx activity following TH supplementa-
tion could be explained by its vitamin contents which reduce
the imbalance between uncontrolled ROS generation and
scavenging enzyme activities [21]. his inding was also sup-
ported by studies in the erythrocytes of young and middle-
aged rats [17] as well as in male BALB/c mice administered
trichlorfon [19] which showed honey supplementation
restored GPx activity.
GSH :GSSG ratio represents the glutathione redox status,
an index of oxidative status in all type of cells. here were no
signiicant changes in blood GSH to GSSG ratios ater EPT
and TH supplementation. his could be explained by inade-
quate antioxidant capability of EPT and TH to restore intra-
cellular GSH [18] or improper sample handling resulting in
GSH which is available in RBC to be oxidized to GSSG.
he plasma SOD level was almost unchanged ater 16
weeks of EPT or TH as supported by previous inding [22].
Our results are inconsistent, however, with those of previous
studies who showed either increased SOD levels in post-
menopausal women with HRT [14] or decreased SOD levels
in pancreas of diabetic rats [18]. hese inconsistencies could
be explained by diference in response between animal and
human following honey supplementation.
he present study showed a reduction in plasma level of
4-HNE, a marker for lipid peroxidation, ater 16 weeks of
EPT and TH supplementation.his could be explained by the
capability of both EPT and TH supplementation to increase
the blood antioxidant capacity and ofset oxidative stress as
evidenced by the increased CAT and GPx activities.
he level of 4-HNE was earlier reported to be higher
in postmenopausal women compared to fertile or pre-
menopausal women [23]. he reduction in oxidative damage
was evident by a decrease in 4-HNE level in the EPT group
and this could be explained by direct efect of estrogen as
antioxidant or its indirect efect via induction of GPx and
CAT activities.
Our inding in TH group could be supported by several
animal studies which showed reduction in lipid peroxida-
tion ater honey supplementation. Honey supplementation
signiicantly reduced malondialdehyde (MDA) levels in the
chemically induced colitis [24] and bile duct ligated [25]
rats. In other studies, honey supplementation signiicantly
reduced MDA levels and restored SOD and CAT activities in
pancreas of diabetic rats [18] and prevented MDA formation
in kidney of spontaneously hypertensive rats [26].
A study on buckwheat honey discovered that phenolic
antioxidants fromprocessed honey are bioavailable and could
increase plasma antioxidant activity and augment defenses
against oxidative stress [27]. hese indings suggest that
phenolic content of THmay also be bioavailable and respon-
sible for its observed antioxidant efects as supported by a
recent inding by Khalil and colleague [11] who revealed that
irradiated TH had the highest total phenolic content among
other types of Malaysian honey, the nearest to the total
phenolic content inManuka honey. In addition to its phenolic
compounds, other constituents in honey may act synergis-
tically and contribute to its antioxidant efects [28]. hese
include vitamins (C and E), enzymes (catalase, peroxidase,
and glucose oxidase), lavonoids, carotenoids, and products
of the Maillard reaction [28, 29]. herefore, the results of
the present study were the irst to demonstrate that honey
supplementation reduces blood oxidative stress comparable
to that of EPT.
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